RankAlpha logo
Back to Rankings

AXGN

AxogenB
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
View Chart
Current thesis
The cleanest post-earnings read is that Axogen paired strong top-line growth with better gross margin and enough confidence to raise full-year revenue guidance, while payer coverage and CMS coding tailwinds give the commercial story more substance than a generic medtech growth narrative [#8-K-2026-04-28] [#10-Q-2026-04-28].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.5.
What can break
Execution risk remains high around translating payer wins and improved CMS reimbursement into durable case-volume growth rather than a one-quarter sentiment boost.
Momentum
89
Value
47
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $42.00 · Bull $48.00 · Bear $33.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $39.55
Why
Momentum89 · Δ7d -3.5
Value47 · Δ7d -0.0
Sentiment47 · Δ7d +9.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
89
34% active weight
Current posture
7d trendFlat
Δ7d
-3.5
Δ21d
-2.9
Value
47
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.3
Sentiment
47
33% active weight
Current posture
7d trendImproving
Δ7d
+9.0
Δ21d
+13.6
Why this grade

Composite grade B. Momentum 88.7 / Value 46.8 / Sentiment 47.2

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$2.1B
Beta
1.00
Shares Out
46.12M
P/E (TTM) · Derived
-133.4
P/S (TTM)
6.82
P/FCF (TTM)
711.09
Rev YoY
+23.5%
EPS YoY
+134.1%
Gross Margin
+74.8%
Op Margin
+1.8%
Net Debt
$14.05M
Current Ratio
4.09
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology